135 related articles for article (PubMed ID: 7674466)
1. Boundary layer infusion of heparin prevents thrombosis and reduces neointimal hyperplasia in venous polytetrafluoroethylene grafts without systemic anticoagulation.
Chen C; Hanson SR; Lumsden AB
J Vasc Surg; 1995 Sep; 22(3):237-45; discussion 246-7. PubMed ID: 7674466
[TBL] [Abstract][Full Text] [Related]
2. Local infusion of heparin reduces anastomotic neointimal hyperplasia in aortoiliac expanded polytetrafluoroethylene bypass grafts in baboons.
Chen C; Lumsden AB; Hanson SR
J Vasc Surg; 2000 Feb; 31(2):354-63. PubMed ID: 10664503
[TBL] [Abstract][Full Text] [Related]
3. Transgraft infusion of heparin to prevent early thrombosis of expanded PTFE grafts in canine femoral veins.
Chen C; Hughes JD; Mattar SG; Hanson SR; Lumsden AB
Ann Vasc Surg; 1996 Mar; 10(2):147-55. PubMed ID: 8733867
[TBL] [Abstract][Full Text] [Related]
4. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
[TBL] [Abstract][Full Text] [Related]
6. Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models.
Lumsden AB; Chen C; Coyle KA; Ofenloch JC; Wang JH; Yasuda HK; Hanson SR
J Vasc Surg; 1996 Nov; 24(5):825-33. PubMed ID: 8918330
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
[TBL] [Abstract][Full Text] [Related]
8. Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model.
Freeman J; Chen A; Weinberg RJ; Okada T; Chen C; Lin PH
Ann Vasc Surg; 2018 May; 49():295-303. PubMed ID: 29197605
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model.
Chen C; Lumsden AB; Ofenloch JC; Noe B; Campbell EJ; Stratford PW; Yianni YP; Taylor AS; Hanson SR
Ann Vasc Surg; 1997 Jan; 11(1):74-9. PubMed ID: 9061143
[TBL] [Abstract][Full Text] [Related]
10. Effects of heparin, desmopressin, and isovolemic hemodilution with dextran on thrombus formation in synthetic vessel grafts inserted into the vena cava of the rabbit.
Frost-Arner L; Bergqvist D
J Vasc Surg; 1998 Sep; 28(3):506-13. PubMed ID: 9737461
[TBL] [Abstract][Full Text] [Related]
11. Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft.
Chen C; Mattar SG; Hughes JD; Pierce GF; Cook JE; Ku DN; Hanson SR; Lumsden AB
Circulation; 1996 Oct; 94(8):1989-95. PubMed ID: 8873678
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylcholine coating of ePTFE reduces platelet deposition and neointimal hyperplasia in arteriovenous grafts.
Chen C; Ofenloch JC; Yianni YP; Hanson SR; Lumsden AB
J Surg Res; 1998 Jul; 77(2):119-25. PubMed ID: 9733597
[TBL] [Abstract][Full Text] [Related]
13. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
Gessaroli M; Bombardi C; Giunti M; Bacci ML
J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
[TBL] [Abstract][Full Text] [Related]
14. The effect of an intraluminal stent on neointimal hyperplasia at an end-to-side polytetrafluoroethylene graft arterial anastomosis.
Chalmers RT; Hoballah JJ; Sharp WJ; Kresowik TF; Corson JD
Am J Surg; 1994 Aug; 168(2):85-90. PubMed ID: 7519832
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration.
Rogers C; Karnovsky MJ; Edelman ER
Circulation; 1993 Sep; 88(3):1215-21. PubMed ID: 8353883
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh.
Kohler TR; Toleikis PM; Gravett DM; Avelar RL
J Vasc Surg; 2007 May; 45(5):1029-1037; discussion 1037-8. PubMed ID: 17466798
[TBL] [Abstract][Full Text] [Related]
17. Improved patency and reduced intimal hyperplasia in PTFE grafts with luminal immobilized heparin compared with standard PTFE grafts at six months in a sheep model.
Pedersen G; Laxdal E; Ellensen V; Jonung T; Mattsson E
J Cardiovasc Surg (Torino); 2010 Jun; 51(3):443-8. PubMed ID: 20523297
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor prevents intimal hyperplasia in rabbit carotid expanded polytetrafluoroethylene grafting.
Harada M; Takenaka H; Ikenaga S; Zhang H; Zempo N; Esato K; Nagano T; Taiji M; Noguchi H
J Vasc Surg; 2002 Apr; 35(4):786-91. PubMed ID: 11932680
[TBL] [Abstract][Full Text] [Related]
19. Neointimal hyperplasia on a cell-seeded polytetrafluoroethylene graft is promoted by transfer of tissue plasminogen activator gene and inhibited by transfer of nitric oxide synthase gene.
Yu H; Dai W; Yang Z; Romaguera RL; Kirkman P; Rowe VL
J Vasc Surg; 2005 Jan; 41(1):122-9. PubMed ID: 15696054
[TBL] [Abstract][Full Text] [Related]
20. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
